الابحاث

South Egypt Cancer Institute

Assiut University

Department of Pediatric Oncology
# Title Research Member Research Year
81 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Prof. Amany Mohamed Ali Ahmed 2018
82 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Tarek Mohamed Abdel Moneim Mohamed Elsaba Ahmed 2018
83 Risk-Adapted, Combined-Modality Therapy for
Unfavorable Pediatric Hodgkin Lymphom 		Prof. Amany Mohamed Ali Ahmed 2018
84 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute 		Dr. Azaa Shibl Sayed Mahmoud 2018
85 Risk-Adapted, Combined-Modality Therapy for Unfavorable Pediatric Hodgkin Lymphom Dr. Samar Muhammad mansour 2018
86 Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources Prof. Heba Abdel-Razik Sayed Hussein 2018
87 Flowcytometric CD135 Expression
and its Impact on Pediatric Acute
Lymphoblastic Leukemia at South Egypt
Cancer Institute 		Prof. Heba Abdel-Razik Sayed Hussein 2018
88 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines Dr. Ahmed Mohammed Morsy Hassan 2017
89 P-459 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines Dr. Khaled Fathy Riad Osman 2017
90 Myocardial Changes in Childhood Cancer Patients Treated with Anthracyclines Prof. Amany Mohamed Ali Ahmed 2017